RI H7896

Students diagnosed with asthma, bronchospasm conditions, or anaphylaxis may possess and self-administer inhaled asthma medications or auto-injectable/intranasal epinephrine during school, at school-sponsored activities, and on school buses with parental consent and physician documentation.

Schools must stock undesignated emergency supplies including at least two doses each of: nasal/injectable glucagon, FDA-approved rescue inhalers, valved holding chambers, and nasal/auto-injector epinephrine in secure, accessible locations.

School teachers, administrators, healthcare personnel, bus drivers, bus monitors, and other trained school personnel may administer these emergency medications to any student believed to be experiencing anaphylaxis, asthma symptoms, or hypoglycemia.

Civil liability immunity is provided to school personnel for ordinary negligence when administering these rescue medications, though immunity does not cover gross negligence or willful/wanton conduct.

Effective date: January 1, 2027.